NO20005060L - Krystallinske former av 1S-[1<alfa>(2S*,3R*), 9<alfa>]6,10- diokso-N-(2-etoksy-5-okso-tetrahydro-3-furanyl)-9[[(1- isokinolyl)karbonyl]amino]oktahydro-6H-piridazino[1,2- a][1,2]diazepin-1-karboksamid - Google Patents
Krystallinske former av 1S-[1<alfa>(2S*,3R*), 9<alfa>]6,10- diokso-N-(2-etoksy-5-okso-tetrahydro-3-furanyl)-9[[(1- isokinolyl)karbonyl]amino]oktahydro-6H-piridazino[1,2- a][1,2]diazepin-1-karboksamidInfo
- Publication number
- NO20005060L NO20005060L NO20005060A NO20005060A NO20005060L NO 20005060 L NO20005060 L NO 20005060L NO 20005060 A NO20005060 A NO 20005060A NO 20005060 A NO20005060 A NO 20005060A NO 20005060 L NO20005060 L NO 20005060L
- Authority
- NO
- Norway
- Prior art keywords
- alpha
- pyridazino
- diazepine
- octahydro
- isoquinolyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/0202—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-X-X-C(=0)-, X being an optionally substituted carbon atom or a heteroatom, e.g. beta-amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Crystallography & Structural Chemistry (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9804367A FR2777279B1 (fr) | 1998-04-08 | 1998-04-08 | Nouvelles formes cristallines du 1s-[1alpha(2s*,3r*), 9 alpha] 6,10-dioxo-n-(2-ethoxy-5-oxo-tetrahydro-3-furanyl) -9[[(1-isoquinolyl)carbonyl]amino]octohydro-6h-pyridazino [1,2-a][1,2]diazepine-1-carboxamide |
PCT/FR1999/000799 WO1999052935A1 (fr) | 1998-04-08 | 1999-04-07 | Formes cristallines du 1s-[1alpha (2s*,3r*),9alpha]-6, 10-dioxo-n- (2-ethoxy-5 -oxo-tetrahydro-3 -furanyl) -9-[[(1-isoquinolyl) carbonyl]-amino] octahydro-6h -piridazino[1, 2-a][1,2] diazepine-1- carboxamide |
Publications (3)
Publication Number | Publication Date |
---|---|
NO20005060D0 NO20005060D0 (no) | 2000-10-06 |
NO20005060L true NO20005060L (no) | 2000-10-06 |
NO327995B1 NO327995B1 (no) | 2009-11-02 |
Family
ID=9524993
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20005060A NO327995B1 (no) | 1998-04-08 | 2000-10-06 | Krystallinsk form av vannfritt 1S-[1alfa(2S*,3R*), 9alfa]6,10-diokso-N-(2-etoksy-5-okso-tetrahydro-3-furanyl)-9[[(1-isokinolyl)karbonyl]amino]oktahydro-6H-piridazino[1,2-a][1,2]diazepin-1-karboksamid (form A), fremgangsmate for fremstilling av denne, og anvendelse av den for fremstilling av et medikament |
Country Status (38)
Country | Link |
---|---|
US (2) | US6544977B1 (no) |
EP (1) | EP1070083B1 (no) |
JP (1) | JP2002511485A (no) |
KR (1) | KR100582981B1 (no) |
CN (1) | CN1202123C (no) |
AP (1) | AP1734A (no) |
AR (1) | AR018328A1 (no) |
AT (1) | ATE315044T1 (no) |
AU (1) | AU758042B2 (no) |
BG (1) | BG64736B1 (no) |
BR (1) | BR9909549A (no) |
CA (1) | CA2325629C (no) |
CU (1) | CU23055A3 (no) |
CZ (1) | CZ299744B6 (no) |
DE (1) | DE69929315T2 (no) |
DK (1) | DK1070083T3 (no) |
EA (1) | EA002761B1 (no) |
EE (1) | EE04467B1 (no) |
ES (1) | ES2253880T3 (no) |
FR (1) | FR2777279B1 (no) |
GE (1) | GEP20032974B (no) |
HK (1) | HK1038575B (no) |
HR (1) | HRP20000665B1 (no) |
HU (1) | HU227561B1 (no) |
ID (1) | ID26290A (no) |
IL (2) | IL138818A (no) |
ME (1) | ME01627B (no) |
NO (1) | NO327995B1 (no) |
NZ (1) | NZ507199A (no) |
PL (1) | PL197016B1 (no) |
RS (1) | RS49916B (no) |
SI (1) | SI1070083T1 (no) |
SK (1) | SK286267B6 (no) |
TR (1) | TR200002914T2 (no) |
TW (1) | TW522152B (no) |
UA (1) | UA71563C2 (no) |
WO (1) | WO1999052935A1 (no) |
ZA (1) | ZA200005438B (no) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK2044025T3 (da) * | 2006-06-30 | 2013-01-14 | Novartis Ag | Quinolinonderivater samt farmaceutiske sammensætninger deraf |
AU2014277867B2 (en) * | 2007-12-04 | 2016-11-03 | Arbutus Biopharma Corporation | Targeting lipids |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6204261B1 (en) * | 1995-12-20 | 2001-03-20 | Vertex Pharmaceuticals Incorporated | Inhibitors of interleukin-1β Converting enzyme inhibitors |
US5552400A (en) * | 1994-06-08 | 1996-09-03 | Sterling Winthrop Inc. | Fused-bicyclic lactams as interleukin-1β converting enzyme inhibitors |
-
1998
- 1998-04-08 FR FR9804367A patent/FR2777279B1/fr not_active Expired - Lifetime
-
1999
- 1999-03-15 TW TW088103966A patent/TW522152B/zh not_active IP Right Cessation
- 1999-03-30 AR ARP990101432A patent/AR018328A1/es active IP Right Grant
- 1999-04-07 SK SK1488-2000A patent/SK286267B6/sk not_active IP Right Cessation
- 1999-04-07 ES ES99911890T patent/ES2253880T3/es not_active Expired - Lifetime
- 1999-04-07 CN CNB998071455A patent/CN1202123C/zh not_active Expired - Fee Related
- 1999-04-07 TR TR2000/02914T patent/TR200002914T2/xx unknown
- 1999-04-07 AP APAP/P/2000/001939A patent/AP1734A/en active
- 1999-04-07 JP JP2000543491A patent/JP2002511485A/ja active Pending
- 1999-04-07 DK DK99911890T patent/DK1070083T3/da active
- 1999-04-07 CA CA2325629A patent/CA2325629C/fr not_active Expired - Fee Related
- 1999-04-07 KR KR1020007011159A patent/KR100582981B1/ko not_active IP Right Cessation
- 1999-04-07 PL PL343350A patent/PL197016B1/pl unknown
- 1999-04-07 RS YUP-608/00A patent/RS49916B/sr unknown
- 1999-04-07 CU CU20000213A patent/CU23055A3/es unknown
- 1999-04-07 NZ NZ507199A patent/NZ507199A/xx not_active IP Right Cessation
- 1999-04-07 ID IDW20002015A patent/ID26290A/id unknown
- 1999-04-07 GE GEAP19995614A patent/GEP20032974B/en unknown
- 1999-04-07 AT AT99911890T patent/ATE315044T1/de active
- 1999-04-07 WO PCT/FR1999/000799 patent/WO1999052935A1/fr active IP Right Grant
- 1999-04-07 ME MEP-2000-608A patent/ME01627B/me unknown
- 1999-04-07 AU AU30416/99A patent/AU758042B2/en not_active Ceased
- 1999-04-07 BR BR9909549-1A patent/BR9909549A/pt not_active Application Discontinuation
- 1999-04-07 CZ CZ20003678A patent/CZ299744B6/cs not_active IP Right Cessation
- 1999-04-07 EE EEP200000586A patent/EE04467B1/xx unknown
- 1999-04-07 DE DE69929315T patent/DE69929315T2/de not_active Expired - Lifetime
- 1999-04-07 HU HU0101586A patent/HU227561B1/hu not_active IP Right Cessation
- 1999-04-07 EA EA200001047A patent/EA002761B1/ru not_active IP Right Cessation
- 1999-04-07 EP EP99911890A patent/EP1070083B1/fr not_active Expired - Lifetime
- 1999-04-07 SI SI9930877T patent/SI1070083T1/sl unknown
- 1999-04-07 US US09/647,858 patent/US6544977B1/en not_active Expired - Lifetime
- 1999-07-04 UA UA2000116295A patent/UA71563C2/uk unknown
-
2000
- 2000-10-02 IL IL138818A patent/IL138818A/en not_active IP Right Cessation
- 2000-10-05 ZA ZA200005438A patent/ZA200005438B/en unknown
- 2000-10-06 BG BG104829A patent/BG64736B1/bg unknown
- 2000-10-06 NO NO20005060A patent/NO327995B1/no not_active IP Right Cessation
- 2000-10-09 HR HR20000665A patent/HRP20000665B1/xx not_active IP Right Cessation
-
2002
- 2002-01-07 HK HK02100107.8A patent/HK1038575B/zh not_active IP Right Cessation
- 2002-11-18 US US10/299,242 patent/US6946459B2/en not_active Expired - Lifetime
-
2005
- 2005-04-14 IL IL168047A patent/IL168047A/en not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP9902136A3 (en) | Novel substituted cyclic amino acid derivatives use as pharmaceutical agents | |
HUP0004310A3 (en) | Cyclic amino acids, and derivatives thereof and pharmaceutical compositions comprising the said compounds as active agents | |
BR9710131A (pt) | Formulações aquosas de peptideos | |
DK0891978T3 (da) | 5H-Thiazol(3,2-a)pyrimidinderivativer | |
NO921256D0 (no) | Aminosyre-beta-lyaseenzyminhibitor som deodoranter | |
IT1282627B1 (it) | Procedimento per la preparazione di perfluoropoliossialchileni perossidici | |
IT1272922B (it) | Procedimento per la preparazione di composti metallocenici | |
NO20005060L (no) | Krystallinske former av 1S-[1<alfa>(2S*,3R*), 9<alfa>]6,10- diokso-N-(2-etoksy-5-okso-tetrahydro-3-furanyl)-9[[(1- isokinolyl)karbonyl]amino]oktahydro-6H-piridazino[1,2- a][1,2]diazepin-1-karboksamid | |
IT1292132B1 (it) | Procedimento per la preparazione di diacereina | |
ITMI981796A0 (it) | Procedimento per la preparazione di r-(-)-carnitina | |
IT1293819B1 (it) | Procedimento per la preparazione di acarbosio | |
IT1267078B1 (it) | Apparecchiatura per la preparazione di soluzioni | |
ITMI942485A0 (it) | Procedimento per la preparazione di epibatidina | |
IT1286527B1 (it) | Procedimento per la sintesi di 2-idrossi-4-alchilossi benzofenone | |
ITMI930340A1 (it) | Procedimento per la preparazione di 5-oxo-2-pirrolidoncarbossilato di piridossina | |
IT1283641B1 (it) | Procedimento per la preparazione di cefalosporine | |
ITMI932694A0 (it) | Procedimento per la preparazione di 2-idrossi-1-4-noftochinoni | |
IT1286498B1 (it) | Procedimento per la preparazione di antibiotici beta-lattamici | |
ITMI20000810A0 (it) | Procedimento per la preparazione di 5'-acetilstavudina | |
IT1275450B (it) | Procedimento per la preparazione di beta-idrossiidroperossidi | |
TH34106EX (th) | แปรงสีฟัน | |
SI0888286T1 (en) | Novel substituted cyclic amino acids as pharmaceutical agents | |
ITRM950548A0 (it) | Procedimento per la preparazione di ammidi | |
IT1271493B (it) | Composizione galenica per la calvizie | |
ITMI940785A0 (it) | Procedimento per la preparazione di esteri 3-vinil-cefalosporanici |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM1K | Lapsed by not paying the annual fees |